According to the research of Future Market Insights, over the projected period, the Glucosamine Supplements Market is expected to expand at a CAGR of 4.8%. The industry's estimated value will increase from US$ 583.6 Million in 2023 to US$ 932.7 Million in 2033. The Glucosamine Supplements Market was worth US$ 567.2 Million at the end of 2022.
| Attributes | Details |
|---|---|
| Market Size Value in 2023 | US$ 583.6 Million |
| Market Forecast Value in 2033 | US$ 932.7 Million |
| Global Growth Rate (2023 to 2033) | 4.8% |
| Forecast Period | 2023 to 2033 |
| Global Market Share of USA, Germany, Japan, and Australia | 69.7% |
Similar to other nutritional supplements, glucosamine supplements are garnering a lot of attention and are becoming more widely known. A National Health Interview Survey conducted by the National Center for Complementary and Alternative Therapy revealed that 17.7% of American adults routinely ingested dietary supplements. 19.9% of them used glucosamine supplements.
It was the second-most well-liked nutritional supplement. Supplements containing glucosamine are formulated using a beneficial substance that keeps joints flexible. Glucosamine supplements come in two major forms: hydrochloride and sulphate. Supplements containing glutamine aid to improve the condition of cartilage, the pliable tissue that cushions bones at joints. It is frequently used to treat inflammatory bowel disease, asthma, allergies, and other disorders in addition to rheumatoid arthritis.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
With a CAGR of 2.9% between 2018 and 2022, the global market for Glucosamine Supplements Market expanded from US$ 505.9 Million to US$ 567.2 Million.
Due to poor diet, a hectic lifestyle, and a rising demand for dietary fibers in functional food and beverage items, chronic diseases including diabetes, cancer, and obesity are becoming more common. This is one of the main factors driving the growth of the glucosamine supplement market. Another significant aspect that is anticipated to boost the growth of the worldwide glucosamine supplements market throughout the projected period is the growing use of glucosamine supplements in the pharmaceutical industry to treat various cardiovascular illnesses, diabetes, and blood pressure.
The development of the global market for glucosamine supplements throughout the forecast period will be influenced by additional variables, such as the branding of dietary supplements by significant manufacturers to preserve their dominance in specific regions.
With a high CAGR of 4.8% over the projected period, it is expected that the global Glucosamine Supplements Market would increase from US$ 583.6 Million in 2023 to US$ 932.7 Million by 2033.
The Glucosamine Supplements market in North America is experiencing steady growth and development. The region has seen a significant increase in the demand for Glucosamine Supplements, largely due to its ability to address joint problems such as arthritis. The popularity of glucosamine supplements has grown significantly over the past decade, with more people turning to natural alternatives for health and wellness solutions.
In North America, the Glucosamine Supplements market is driven by factors such as growing awareness about the benefits of these products, increasing consumer expenditure on healthcare products and services, rising prevalence of joint-related disorders among aging populations and an expanding retail sector. Furthermore, new product launches from various manufacturers are also contributing to the growth of this market in this region.
Europe is a key market for glucosamine supplements. The demand for natural remedies and dietary supplements has been on the rise in Europe, particularly in the United Kingdom, Germany, France and Spain. With increasing health awareness among Europeans, there has been a surge of interest in glucosamine as an effective alternative to traditional medication.
Glucosamine is used by many people with joint pain or arthritis to help reduce symptoms and improve mobility. It is available as an over-the-counter supplement in many European countries including France, Italy and Austria. The use of glucosamine supplements has grown significantly across Europe over the past decade due to rising consumer demand for natural remedies with fewer side effects than pharmaceutical medications.
The market for Glucosamine Supplements is expanding rapidly in the Asia Pacific region. The demand for these supplements, which are used to relieve pain caused by joint inflammation and other joint-related conditions, has increased steadily over the past few years. This is due to an increase in awareness about the health benefits of taking glucosamine supplements as well as a growing number of people suffering from joint-related conditions.
The Asia Pacific region is currently one of the largest markets for glucosamine supplements, with China and India leading in terms of sales volumes. Factors such as rising incomes, an increase in elderly population and greater access to healthcare are also contributing to this growth. Additionally, countries like Japan and South Korea have also seen a surge in popularity due to their aggressive marketing campaigns that promote these products.
Principal Consultant
The food and beverage industry is always looking for new ways to improve the health of their products. Glucosamine supplements are one of the latest innovations being used in this industry. Glucosamine is an amino sugar derived from glucose, which has been found to have potential health benefits due to its anti-inflammatory properties. It can be found in certain foods and beverages, such as seafood, chicken, pork and dairy products, as well as nutraceuticals (supplements).
Glucosamine supplements are commonly used by individuals who suffer from joint pain or arthritis related inflammation due to its reported ability to reduce swelling and tenderness. It is also being used in a variety of food products from snacks to energy drinks, providing consumers with added nutrition without additional calories or fat.
Glucosamine is known for its anti-inflammatory properties which help reduce joint pain and discomfort caused by arthritis or injury. Dairy cows are often under pressure due to their long periods of production which means they need extra support with joint health. Glucosamine provides this support by supporting the breakdown of cartilage tissue while providing nutrients that help build new cartilage cells.
Glucosamine supplements are used in dairy products to improve the health of cows and other animals. As an important dietary supplement, glucosamine helps to maintain healthy joints and bones in larger livestock, including cows. It can be found in a variety of dairy products, from cheese and yogurt to milk and cream.
The competitive landscape of the glucosamine supplements market is highly fragmented, with a large number of players operating at both the global and regional levels. Some of the major players in the market include GlaxoSmithKline, Pfizer Inc., Merck & Co., Inc., Sanofi, and Novartis AG. These players are focusing on strategic partnerships and collaborations, as well as product innovation and expansion in order to increase their market share.
Additionally, many smaller players also exist, such as Solgar, BioTech USA, Nature's Best, and others. The market is also witnessing an increasing number of private label and store brand products, which are typically less expensive than those of major brands. This competition is likely to continue to drive innovation and price competition in the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD Million for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; MEA |
| Key Countries Covered | Philippines, India, Malaysia, Thailand, USA, Germany, China, Japan, Denmark, Canada, Mexico, Poland, UK, Turkey, France, Italy, Spain, South Korea, Russia, Australia, Brazil, Argentina, South Africa |
| Key Segments Covered | Type, Product Type, Application, Region |
| Key Companies Profiled | GlaxoSmithKline; Pfizer Inc.; Merck & Co. Inc.; Sanofi; Novartis AG; Solgar; BioTech USA; Nature's Best; Mylan N.V.; Teva Pharmaceutical Industries Ltd. |
| Report Coverage | DROT Analysis, Market Forecast, Company Share Analysis, Market Dynamics and Challenges, Competitive Landscape and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The Glucosamine Supplements market will reach nearly US$ 583.6 Million by 2023.
The Glucosamine Supplements market is expected to rise at a CAGR of 4.8%.
USA, Canada, Mexico, Argentina, Brazil, Germany, UK, France, Turkey, Italy, Russia, Spain China, Japan, India, Indonesia, South Korea, Australia are the major countries driving the demand for Glucosamine Supplements market.
The China Glucosamine Supplements market will grow at 3.9% CAGR between 2023 and 2033.
The India Glucosamine Supplements market will grow at 5.4% CAGR between 2023 and 2033.
The UK Glucosamine Supplements market will grow at 5.4% CAGR between 2023 and 2033.
• GlaxoSmithKline • Pfizer Inc. • Merck & Co. Inc. • Sanofi • Novartis AG
The global demand for Glucosamine Supplements market is forecasted to surpass US$ 932.7 Million by the year 2033.
Explore Food and Beverage Insights
View Reports
Glucosamine Supplement Market
